Press Releases

TauRx Therapeutics to present at Social Care Conference in London on 25th March

Mar 23 - 2014 05:00 AM
TauRx Chairman and London-based principal investigator will highlight how access to investigational treatments for Alzheimer’s is changing the care model for people with cognitive impairment – now and in the future
Read more

Erste deutsche Patienten melden sich zu den klinischen Phase-3-Studien von LMTX™ zur Alzheimer-Krankheit an

Jan 09 - 2014 08:46 AM
Klinische Studien beginnen in Deutschland mit einem Tau-Aggregationshemmer (TAI) der zweiten Generation mit dem Ziel, das Fortschreiten von Alzheimer zu stoppen
Read more

First German patients enroll in Phase 3 clinical trials of LMTX™ for Alzheimer’s Disease

Jan 08 - 2014 06:00 AM
Clinical trials get under way in Germany with a second-generation tau aggregation inhibitor (TAI) aimed at halting the progression of Alzheimer’s
Read more

TauRx Expands Alzheimer’s Clinical Trials in the United States

Jan 05 - 2014 06:00 AM
Clinical research centers added to allow more patients to access a tau-based investigational treatment for mild to moderate Alzheimer’s disease
Read more

Chairman of TauRx and Dr Emer MacSweeney of Re:Cognition Health to speak at ADI Middle East Conference in Dubai on 8-9 December

Dec 06 - 2013 04:54 PM
Two innovative UK thought leaders in Alzheimer’s disease will be speaking at the upcoming 2nd Middle East and North Africa Conference of Alzheimer's Disease International this weekend.
Read more